Cadence wins Ofirmev patent infringement case

19-11-2013

Cadence Pharmaceuticals announced on November 14 that the US District Court for the District of Delaware ruled in its favour in its patent infringement suit against Exela Pharma Sciences LLC.


Cadence, Ofirmev, patent infringement, Exela

LSIPR